Adtalem Global Education Inc

Adtalem Global Education Inc(ATGE)股票分析

$98.540

+1.941 (+1.97%)收盘时

Loading chart…
最高
99.720
开盘
96.000
成交量加权均价
98.05
成交量
683.15K
市值
2.48B
最低
95.900
成交额
66.99M
企业价值/息税折旧摊销前利润(TTM)
9.75

Adtalem Global Education Inc. is a provider of healthcare education in the United States, preparing a diverse workforce with academic programs. Its healthcare programs include nursing, medicine, veterinary medicine, social and behavioral sciences and more. Its segments include Chamberlain, Walden, and Medical and Veterinary. Chamberlain segment offers degree and certificate programs in the nursing and health professions postsecondary education industry. Walden segment offers degree and certificate programs, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. Medical and Veterinary segment offers degree and certificate programs in the medical and veterinary postsecondary education industry. This segment includes American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine.

AI 分析 of Adtalem Global Education Inc (ATGE)

持有

Adtalem Global Education Inc (ATGE) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company shows solid financial performance and positive analyst sentiment, the technical indicators suggest a bearish trend, and there are no strong trading signals or immediate positive catalysts to justify an entry point right now.

分析师评级(5)

上行空间 +63.39%
持有
2 买入
3 持有
0 卖出
当前: 98.54
最低
138.00
平均
161.00
最高
175.00

BMO Capital

2026-01-30

目标价

$138

跑赢大盘

Barrington

2025-10-15

目标价

$170

跑赢大盘

Barrington

2025-08-08

目标价

$150

跑赢大盘

Baird

2025-08-08

目标价

$169

跑赢大盘

BMO Capital

2025-05-12

目标价

$132

跑赢大盘

估值指标

Adtalem Global Education Inc(ATGE)当前预期市盈率为 15.98,5 年平均预期市盈率为 11.38。

预期市盈率

高估
5 年均值 P/E
11.38
当前P/E
15.98
高估
14.58
低估
8.17

预期 EV/EBITDA

高估
5 年均值 EV/EBITDA
7.85
当前EV/EBITDA
9.75
高估
9.40
低估
6.29

预期市销率

高估
5 年均值 P/S
1.50
当前P/S
2.27
高估
1.99
低估
1.00

Alphio AI 对 ATGE 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%ATGE

$150.34

情景价格

基

基准

基准 · 50%ATGE

$141.08

情景价格

悲

悲观

悲观 · 25%ATGE

$125.27

情景价格

持有 ATGE 的大户

Ö

ÖKoworld Lux S.A.

+ 持有ATGE

-0.36%

3个月收益率

A

Ariel Investments, LLC

+ 持有ATGE

-1.61%

3个月收益率

事件时间线

2026-01-28 (ET)

16:30:00

Adtalem Maintains FY 2026 Revenue Guidance at $1.9B-$1.94B

16:20:00

Adtalem Global Education Q2 Revenue $503.385M Beats Expectations

2025-12-15 (ET)

10:10:00

Adtalem Global Education Stock Rises 6.5% to $98.92

08:10:00

Adtalem Completes $150M Share Repurchase and Secures $750M New Buyback Authorization

2025-11-05 (ET)

07:25:26

Adtalem confirms FY26 adjusted EPS forecast of $7.60-$7.90, aligning with consensus of $7.81

资讯

ATGE 常见问题 —— 由 Alphio AI 解答

Adtalem Global Education Inc. is a provider of healthcare education in the United States, preparing a diverse workforce with academic programs. Its healthcare programs include nursing, medicine, veterinary medicine, social and behavioral sciences and more. Its segments include Chamberlain, Walden, and Medical and Veterinary. Chamberlain segment offers degree and certificate programs in the nursing and health professions postsecondary education industry. Walden segment offers degree and certificate programs, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. Medical and Veterinary segment offers degree and certificate programs in the medical and veterinary postsecondary education industry. This segment includes American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. It operates in the Academic & Educational Services sector (SERVICES-EDUCATIONAL SERVICES industry).

Adtalem Global Education Inc (ATGE) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company shows solid financial performance and positive analyst sentiment, the technical indicators suggest a bearish trend, and there are no strong trading signals or immediate positive catalysts to justify an entry point right now.

5 analysts cover ATGE: 2 rate it Buy, 3 Hold and 0 Sell. The average price target is 161.00.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易